evaluation effect of Pentoxifylline in sepsis.

Phase 3

Recruiting

• Conditions: neonatal late sepsis.; Other sepsis

• Registration Number: IRCT20180404039187N7
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Preterm neonate with positive blood culture of sepsis
clinical signs of sepsis:
temprature instability
respiratory disorders
cardiovascular disorders
gastrointestinal disorders
preterm neonates with late onset sepsis(having sepsis 72 hours after birth)

Exclusion Criteria

neonate with cranial hemorrhage
maternal infection
renal disorders
neonate with tolerance to xanthine products that cause anaphylactic reaction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of hospitalized days. Timepoint: During the study. Method of measurement: Count the days of hospitalization.;Duration of making CRP marker negative. Timepoint: At the beginning and during the study. Method of measurement: laboratory tests.;Need for intubation and mechanical ventilarion. Timepoint: During the study. Method of measurement: Checking patient records.;Metabolic acidosis. Timepoint: During the study. Method of measurement: Laboratory test(ABG).;Duration needed for oxygene therapy. Timepoint: During the study. Method of measurement: Counting days under oxygen therapy.